| 000 | 01397 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515104746.0 | ||
| 264 | 0 | _c20080502 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a1365-2362 | ||
| 024 | 7 |
_a10.1111/j.1365-2362.2007.01915.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aValent, P | |
| 245 | 0 | 0 |
_aIron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical investigation _cMar 2008 |
||
| 300 |
_a143-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aChelation Therapy _xmethods |
| 650 | 0 | 4 |
_aErythrocyte Transfusion _xadverse effects |
| 650 | 0 | 4 |
_aFerritins _xblood |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIron Chelating Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aIron Overload _xphysiopathology |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xcomplications |
| 700 | 1 | _aKrieger, O | |
| 700 | 1 | _aStauder, R | |
| 700 | 1 | _aWimazal, F | |
| 700 | 1 | _aNösslinger, T | |
| 700 | 1 | _aSperr, W R | |
| 700 | 1 | _aSill, H | |
| 700 | 1 | _aBettelheim, P | |
| 700 | 1 | _aPfeilstöcker, M | |
| 773 | 0 |
_tEuropean journal of clinical investigation _gvol. 38 _gno. 3 _gp. 143-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2362.2007.01915.x _zAvailable from publisher's website |
| 999 |
_c17725409 _d17725409 |
||